Corcept Therapeutics Incorporated (CORT): Price and Financial Metrics
CORT Price/Volume Stats
| Current price | $69.71 | 52-week high | $117.33 |
| Prev. close | $64.68 | 52-week low | $22.00 |
| Day low | $65.77 | Volume | 1,038,059 |
| Day high | $70.73 | Avg. volume | 1,404,918 |
| 50-day MA | $65.17 | Dividend yield | N/A |
| 200-day MA | $51.50 | Market Cap | 7.35B |
CORT Stock Price Chart Interactive Chart >
Corcept Therapeutics Incorporated (CORT) Company Bio
Corcept Therapeutics engages in the discovery, development, and commercialization of drugs for the treatment of metabolic, oncologic, and psychiatric disorders. The company was founded in 1998 and is based in Menlo Park, California.
CORT Price Returns
| 1-mo | 17.22% |
| 3-mo | 11.91% |
| 6-mo | 47.44% |
| 1-year | 203.09% |
| 3-year | 212.32% |
| 5-year | 430.52% |
| YTD | 38.34% |
| 2024 | 55.14% |
| 2023 | 59.92% |
| 2022 | 2.58% |
| 2021 | -24.31% |
| 2020 | 116.20% |
Continue Researching CORT
Here are a few links from around the web to help you further your research on Corcept Therapeutics Inc's stock as an investment opportunity:Corcept Therapeutics Inc (CORT) Stock Price | Nasdaq
Corcept Therapeutics Inc (CORT) Stock Quote, History and News - Yahoo Finance
Corcept Therapeutics Inc (CORT) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...